VITA 34 AG VITA 34 AG announced an upcoming change in the Management Board of the Company. As of 1 August of this year, Mr. Dirk Plaga (57) will accordingly assume the position of Chief Financial Officer of the Company. Dirk Plaga has extensive experience in M&A, corporate finance and post-merger integration in the pharmaceutical and biotech industries, among others.
Most recently, he served as Executive Vice President and Global Head of Finance for Evotec SE, which is also listed in the Prime Standard. Mr. Andreas Schafhirt, who filled the position on an interim basis since last year, will continue to support the company as an advisor and ensure a smooth transition in day-to-day business and ongoing projects.
